Hamden, CT, United States of America

Fred Christopher Zusi

USPTO Granted Patents = 14 

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 1997-2008

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Fred Christopher Zusi: Innovator in Pharmaceutical Compounds

Introduction

Fred Christopher Zusi is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work primarily focuses on developing innovative compounds that address various medical conditions.

Latest Patents

Among his latest patents, Zusi has developed pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising these compounds. The invention provides for compounds with a specific formula, which are designed to treat inflammatory and immune diseases. Another significant patent involves imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds, also aimed at addressing similar health issues.

Career Highlights

Zusi is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His extensive research and development efforts have led to advancements in treatments for various diseases.

Collaborations

Throughout his career, Zusi has collaborated with esteemed colleagues, including Kenneth M. Tramposch and Yuping Qiu. These partnerships have further enhanced the impact of his work in the field.

Conclusion

Fred Christopher Zusi's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through science. His patents reflect a dedication to developing effective treatments for inflammatory and immune diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…